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Abstract Hainantoxin-I is a novel peptide toxin, puri¢ed from
the venom of the Chinese bird spider Selenocosmia hainana
( =Ornithoctonus hainana). It includes 33 amino acid residues
with a disul¢de linkage of I^IV, II^V and III^VI, assigned by
partial reduction and sequence analysis. Under two-electrode
voltage-clamp conditions, hainantoxin-I can block rNav1.2/L1
and the insect sodium channel para/tipE expressed in Xenopus
laevis oocytes with IC50 values of 681 6 WM and 4.3 1 0.3 WM
respectively. The three-dimensional solution structure of hainan-
toxin-I belongs to the inhibitor cystine knot structural family
determined by two-dimensional 1H nuclear magnetic resonance
techniques. Structural comparison of hainantoxin-I with those
of other toxins suggests that the combination of the charged
residues and a vicinal hydrophobic patch should be responsible
for ligand binding. This is the ¢rst report of an insect sodium
channel blocker from spider venom and it provides useful infor-
mation for the structure^function relationship studies of insect
sodium channels.
6 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Voltage-gated sodium channels (VGSCs) are major contrib-
utors to the initiation and propagation of the action potentials
in excitable cells. They are composed of a functional pore-
forming K subunit (260 kDa) associated with up to three
auxiliary L subunits (21^23 kDa) [1,2]. To date nine mamma-
lian (Nav1.1^Nav1.9) and three invertebrate VGSC subtypes
have been cloned, functionally expressed and characterized.
With more than 75% sequence identity with one another,
these subtypes show relatively similar pharmacological prop-
erties in di¡erent expression systems, although their response
to certain ligands can be quite di¡erent [3,4].
VGSCs have been highly conserved during evolution [5].
Although the receptor sites have been predominantly identi-
¢ed and characterized by vertebrate preparations, binding ex-
periments indicate that insect neuronal VGSCs possess similar
receptor sites [6]. However, there are also di¡erences between
the two classes of VGSCs. Compared with vertebrate VGSCs,
insect VGSCs are generally more sensitive to tetrodotoxin
(TTX). Furthermore, some g-toxins (e.g. g-conotoxin MVIIC
and g-agatoxin IVA) fail to target mammal Naþ channels,
but block TTX-sensitive (TTX-S) Naþ currents in insect mem-
branes [7]. To date, more than six neuronal receptor sites on
VGSCs have been identi¢ed to bind toxins [8].
Spider venoms contain a variety of toxins that target vol-
tage-gated ion channels and have been used as a potential
source of new compounds with speci¢c pharmacological prop-
erties. According to their functional characteristics on
VGSCs, the 27 spider peptides or homologues from the
PubMed database (www.pubmed.com) can be divided into
two groups: depressant and excitatory toxins. Depressant tox-
ins (e.g. HNTX-IV and HWTX-IV) speci¢cally inhibit the
mammal neuronal TTX-S VGSCs through a mechanism quite
similar to that of TTX without a¡ecting the activation or
inactivation kinetics [9,10]. Excitatory toxins (e.g. W-agatoxins
and N-atracotoxins), acting at site 3 on the vertebrate and/or
insect VGSCs, inhibit the inactivation in a similar manner to
K-scorpion toxins and ATXII [11,12]. Among these site 3
toxins, some speci¢cally activate insect VGSCs (e.g. W-agatox-
ins I and IV, curtatoxins I^III) [11,12] ; several target both
mammalian and insect VGSCs (e.g. N-ACTX-Ar1 and
N-ACTX-Hv1a) [13] and others show no e¡ect on insect
VGSCs (e.g. N-ACTX-HV1b) [14]. Radio-ligand binding ex-
periments reveal that these site 3 toxins compete with
[125I]Lqh II or [125I]LqhKIT, two well-de¢ned ligands of re-
ceptor site 3, in both rat brain and cockroach neuronal mem-
branes. They are extremely potent and de¢ne a new class of
toxins a¡ecting both insect and mammalian VGSCs [15,16].
The Chinese bird spider Selenocosmia hainana ( =Ornithoc-
tonus hainana) is distributed in the hilly areas of Hainan prov-
ince in southern China [17]. Its crude venom can inhibit
TTX-S Naþ currents induced on neuroblastomaUglioma hy-
brid (NG108-15) cells with the IC50 value of 1.8 mg/l [18].
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Hainantoxin-I (HNTX-I) is the most abundant component in
the crude venom, but previous patch-clamp experiments indi-
cated that HNTX-I failed to a¡ect the normal activities of
TTX-S VGSCs, voltage-gated delay-recti¢ed outward potassi-
um channels and voltage-gated calcium channel on NG108-15
cells [18]. In the present study, we report the characterization
of HNTX-I inhibiting the TTX-S insect VGSC para/tipE and
rNav1.2/L1 channel expressed in Xenopus laevis oocytes, the
determination of its disul¢de linkage, and the solution struc-
ture determined using 2D 1H nuclear magnetic resonance
(NMR) spectroscopy as a typical inhibitor cystine knot
(ICK) motif [19]. Furthermore, a detailed comparison of the
structure of HNTX-I and other previously known toxins tar-
geting ion channels provides a basis for deducing the struc-
ture^function relationships for these molecules and their in-
teraction with potential target receptors.
2. Materials and methods
2.1. Toxin puri¢cation and sequencing
The venom from adult female O. hainana spiders was collected and
puri¢ed by ion-exchange chromatography and reversed-phase high
performance liquid chromatography (RP-HPLC) as described in our
previous work [9]. The molecular mass was determined by matrix-
assisted laser desorption/ionization time-of-£ight (MALDI-TOF)
mass spectrometry on a Voyager-DE1 STR Biospectrometry1 work-
station. The entire amino acid sequence was obtained from a single
sequencing run on an Applied Biosystems/Perkin-Elmer Life Sciences
Procise 491-A protein sequencer.
2.2. Assignment of the disul¢de bonds of HNTX-I
To determine the speci¢c disul¢de connections of HNTX-I, partial
reduction by Tris (2-carboxyethyl)phosphine (TCEP) at low pH was
employed [9]. 0.1 mg HNTX-I, dissolved in 10 Wl of 0.1 M citrate
bu¡er (pH 3) containing 6 M guanidine-HCl, was partially reduced by
adding 10 Wl of 0.1 M TCEP at 40‡C for 10 min at pH 3. The
intermediates were isolated by RP-HPLC and their masses were de-
termined by MALDI-TOF mass spectrometry. Appropriate inter-
mediates containing free thiols were dried and then alkylated by add-
ing 100 Wl of 0.5 M iodoacetamide (pH 8.3). The alkylated peptide
was desalted by RP-HPLC and then submitted to an Applied Biosys-
tems 491-A protein sequencer.
2.3. Expression in X. laevis oocytes
For the expression in X. laevis oocytes, the para/pGH19-13-5 vector
[20], tipE/pGH19 vector [21,22] and rBrainII(Nav1.2)/pLCT1 vector
[23] were linearized with NotI and transcribed with the T7 mMES-
SAGE-mMACHINE kit (Ambion, USA). The L1 gene was subcloned
into pSP64T [24]. For in vitro transcription, L1/pSP64T was ¢rst lin-
earized with EcoRI. Next, capped cRNA was synthesized from the
linearized plasmid using the large-scale SP6 mMESSAGE-mMA-
CHINE transcription kit (Ambion).
The harvesting of oocytes from anesthetized female X. laevis frogs
was as previously described [25]. Oocytes were injected with 50 nl of
cRNA at a concentration of 1 ng/nl using a Drummond micro-injec-
tor (USA). The ND96 solution used for incubating the oocytes con-
tained (in mM): NaCl 96, KCl 2, CaCl2 1.8, MgCl2 2 and HEPES 5
(pH 7.4), supplemented with 50 mg/l gentamicin sulfate. HNTX-I
powder was dissolved in ND96 containing 0.1% bovine serum albu-
min.
2.4. Electrophysiological recordings in Xenopus oocytes
Two-electrode voltage-clamp recordings were performed at room
temperature (18^22‡C) using a GeneClamp 500 ampli¢er (Axon In-
struments, USA) controlled by a pClamp data acquisition system
(Axon Instruments). Whole-cell currents from oocytes were recorded
3^4 days after injection. Voltage and current electrodes were ¢lled
with 3 M KCl. Resistances of both electrodes were kept as low as
possible (6 0.5 M6). Bath solution composition was (in mM): NaCl
96, KCl 2, CaCl2 1.8, MgCl2 2 and HEPES 5 (pH 7.4). Using a four-
pole low-pass Bessel ¢lter, currents were ¢ltered at 2 kHz and sampled
at 10 kHz. Leak and capacitance subtraction were performed using a
P/4 protocol. Current traces were evoked in an oocyte expressing the
cloned VGSCs by depolarizations between 370 and 40 mV, using 10
mV increments, from a holding potential of 390 mV. Curve manip-
ulations were performed using pClamp8 (Axon Instruments) and Ori-
gin software (Microcal, USA).
2.5. NMR spectroscopy
NMR samples were prepared by dissolving the native HNTX-I in
500 Wl of 20 mM deuterium sodium acetate bu¡er (H2O/D2O, 9/1, v/v)
with a ¢nal concentration of 4.5 mM (pH 4.0). All NMR spectra were
observed on a 500 MHz Bruker DRX-500 spectrometer with a sample
temperature of 298 K. The hydrogen^deuterium exchange experiments
were carried out by recording a series of 1D spectra after the lyophi-
lized sample was redissolved in D2O. Several sets of 2D spectra were
recorded in a phase-sensitive mode by the time-proportional phase
incrementation method following standard pulse sequences and phase
cycling. Solvent suppression was achieved by the presaturation meth-
od. Total correlated spectroscopy spectra were obtained with a mixing
time of 100 ms. Nuclear Overhauser e¡ect spectroscopy (NOESY)
spectra were recorded with a mixing time of 200 ms in D2O and of
100, 200 and 400 ms in H2O. All spectra were processed and analyzed
using Felix 98.0 software (Biosym Technologies) running on a Silicon
Graphics O2 workstation.
2.6. Structure calculations
Distance constraints were obtained from the intensities of cross-
peaks in NOESY spectra with a mixing time of 200 ms. All NOE
data were classi¢ed into four distance ranges, 1.8^2.7 AS , 1.8^3.5 AS ,
1.8^5.0, 1.8^6.0 AS , corresponding to strong, medium, weak and very
weak NOE values, respectively. Pseudo-atom corrections were applied
to non-stereospeci¢cally assigned methyl and methylene protons ac-
cording to the method of Wu«thrich [26]. Ten P dihedral angle re-
straints derived from 3JNHCKH coupling constants were restrained
to 3120U 30‡ for 3JNHCKHv 8.80 Hz and 3120U40‡ for 8.009
3JNHCKH6 8.80 Hz. Three distance constraints were added to every
disul¢de bond. The corresponding distances were 2.02U 0.02 AS ,
2.99U 0.5 AS , and 2.99U 0.5 AS for S(i)^S(j), S(i)^CL(j), and S(j)^
CL(i), respectively. Ten hydrogen bond constraints con¢ned the
NH(i)^O(j) and N(i)^O(j) distances as 1.8^2.3 AS and 2.8^3.3 AS , re-
spectively, according to slowly exchanging amide protons and NOE
patterns. Structure calculations of HNTX-I were run on a Silicon
Graphics workstation using the standard protocol of the X-PLOR
3.851 program [27].
3. Results
3.1. Isolation and sequencing of HNTX-I
HNTX-I was puri¢ed by a combined use of ion-exchange
HPLC and RP-HPLC as described before [9] (Fig. 1). The
amino acid sequence of HNTX-I determined by Edman deg-
radation, as shown in Fig. 2, consists of 33 amino acid resi-
dues including six Cys residues. Its experimental average mo-
lecular mass is 3608.02 Da and monoisotopic molecular mass
is 3605.62 Da, consistent with the calculated molecular mass
for HNTX-I-amide. Hence, it was concluded that HNTX-I is
C-terminally amidated. The amino acid sequence of HNTX-I
reported here redressed the incorrect four residues at the C-
terminus of the ¢rst reported sequence of HNTX-I [18]. The
¢nal sequence of this toxin has been con¢rmed by the data of
disul¢de bond assignment and the 2D-NMR experiment in
this study.
3.2. Assignment of the disul¢de bonds of HNTX-I
Reduction of HNTX-I by TCEP led to the isolation of
three partially reduced peptides (Fig. 3, peaks I, IIa and
IIb), determined by MALDI-TOF mass spectrometry analy-
sis. The three peaks were collected and alkylated rapidly with
iodoacetamide following puri¢cation by analytical RP-HPLC.
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Molecular weight determination and sequencing indicated
that the free thiols of these three peptides had been alkylated.
In Fig. 4A, Pth-CM-Cys signals were observed in the chro-
matograms at the 2nd and 17th cycles when sequencing alky-
lated peak I, while no signals were observed at the remaining
cysteine cycles. The result indicates that the only reduced di-
sul¢de bond is Cys2^Cys17. When sequencing alkylated peak
IIa, Pth-CM-Cys signals were observed at the 2nd, 9th, 17th
and 22nd cycles (Fig. 4B), indicating that Cys16 is still linked
to Cys29 by a disul¢de bond. For alkylated peak IIb, Pth-
CM-Cys signals were observed at the 2nd, 16th, 17th, and
29th sequencing cycles (Fig. 4C), suggesting that the remain-
ing disul¢de bond is Cys9^Cys22. Accordingly, the disul¢de
linkage of HNTX-I was determined to be Cys2^Cys17, Cys9^
Cys22 and Cys16^Cys29. This disul¢de pattern (I^IV, II^V
and III^VI) is frequently found in a variety of toxic and in-
hibitory polypeptides from biologically diverse sources.
3.3. E¡ects of HNTX-I on sodium channel currents
Using the two-electrode voltage-clamp technique on X. lae-
vis oocytes, a pharmacological comparison was made regard-
ing the e¡ects of HNTX-I on two di¡erent cloned sodium
channels. Current traces were evoked using 25 ms step depo-
larizations to a voltage range between 370 and 40 mV de-
pending on the sodium channel, from a holding potential of
390 mV. The e¡ect of HNTX-I on a TTX-S vertebrate neuro-
nal VGSC (Nav1.2 from rat co-expressed with the vertebrate
Fig. 1. Puri¢cation of HNTX-I. A: Ion-exchange HPLC pro¢le of
crude O. hainana venom (the elution site of HNTX-I is labelled).
Lyophilized venom was applied to a Waters Protein-Pa1 CM
15HR ion-exchange column (10U100 mm). Bu¡er A: 0.1 M
NaH2PO4 ; bu¡er B: 0.1 M Na2HPO4 ; bu¡er C: 1 M NaCl; bu¡er
D: ddH2O; £ow rate, 3.0 ml/min; gradient: A 8%, B 2%, C 0^90%
0^50 min; wavelength detector: 280 nm. B: Analytical RP-HPLC
pro¢le of HNTX-I. The peak labeled with HNTX-I in ion-exchange
chromatography was applied to a Vydac C18 column (4.6U250
mm). Elution was performed with a linear gradient of 15^45% ace-
tonitrile/0.1% tri£uoroacetic acid in ddH2O for 45 min at a £ow
rate of 0.7 ml/min.
Fig. 2. Comparison of the amino acid sequence of HNTX-I with
HWTX-I and previously described VGSC blockers from the venom
of the Chinese bird spider Ornithoctonus. C represents an amidated
C-terminus. # shows the sequence of HNTX-III from the SwissProt
knowledgebase under accession number P83464. shows the ex-
tremely well conserved residues important for their functions. Identi-
cal residues and conservatively substituted residues are shaded in
black and gray, respectively. The disul¢de bridge pattern of these
toxins is indicated above the sequences. HWTX-I is an N-type Ca2þ
channel blocker [38]. HWTX-IV, HNTX-III^V block TTX-S
VGSCs expressed in adult rat dorsal root ganglion neurons
[9,10,30]. HNTX-I blocks rNav1.2/L1 and para/tipE expressed in
X. laevis oocytes.
Fig. 3. Analytical RP-HPLC pro¢le of partial reduction of HNTX-I
by TCEP. The ¢ve chromatographic peaks contain intact peptide
and partially reduced intermediates, respectively. The main peak
(peak N) represents intact HNTX-I, whose observed mass is the
same as the native HNTX-I. Peak I with a mass 2 Da greater than
that of native peptide indicates one of the three disul¢de bonds pos-
sibly reduced. The masses of peaks IIa and IIb are both 4 Da heav-
ier than the native HNTX-I, suggesting that two disul¢de bonds are
reduced to four free thiol groups. Peak R represents completely re-
duced peptide with a mass 6 Da heavier than the intact peptide.
Fig. 4. RP-HPLC sequencing pro¢le of partially reduced intermedi-
ates after modi¢cation with iodoacetamide. Cys residues occur at
cycles 2, 9, 16, 17, 22 and 29. The elution position of Pth-CM-Cys
is marked with arrows. A: The Cys residue cycles of alkylated peak
I. B: The Cys residue cycles of alkylated peak IIa. C: The Cys resi-
due cycles of alkylated peak IIb.
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L1 subunit) was compared to an insect neuronal VGSC (para
from Drosophila melanogaster co-expressed with the insect
tipE subunit). HNTX-I causes a block of 100% when applied
to both VGSCs (Fig. 5). No shift in the I^V curve was ob-
served (Fig. 6). Although active on both neuronal VGSCs,
HNTX-I possesses higher potency on para/tipE (as shown in
Fig. 5). The following IC50 values were obtained after a sig-
moidal ¢t of the data: para/tipE 4.3 U 0.3 WM and Nav1.2/L1
68U 6 WM. HNTX-I is more than 15-fold more potent on
para/tipE as compared to Nav1.2/L1.
3.4. Structure calculations and evaluation
Sequence-speci¢c resonance assignments were performed
according to the standard method [26]. All of the backbone
protons and more than 96% of the side chain protons were
identi¢ed in our previous paper [28]. A total of 329 non-re-
dundant distance constraints and 10 dihedral constraints were
used for the ¢nal calculations of HNTX-I. A family of 20
accepted structures with lower energies and better Ramachan-
dran plots were selected to represent the 3D solution structure
of HNTX-I. The structures have no distance violations greater
than 0.2 AS and no dihedral violations greater than 2.0‡. Fur-
thermore, they also have no serious contacts and no distor-
tions, as shown by the low values of the mean Lennard^Jones
potential and the small deviations from ideal bond lengths
Fig. 5. E¡ects of HNTX-I on VGSCs. Current traces were evoked
by depolarizations ranging from 310 to 0 mV depending on the so-
dium channel, from a holding potential of 390 mV. * represents
control conditions where no toxin was added. A,B: Left column
represents the maximum e¡ects of HNTX-I obtained on para/tipE
(addition of 20 WM) and Nav1.2/L1 (addition of 200 WM) expressed
in X. laevis oocytes. Right column represents the comparison of
their dose^response curves. A sodium current block was observed
for both VGSCs. Data are meanUS.E.M. of at least three experi-
ments. IC50 values are discussed in the text. C: Both TTX-S and
TTX-R VGSCs were una¡ected by 100 WM HNTX-I on dorsal root
ganglion (DRG) neurons, isolated from adult rat by the method de-
scribed in [9,10]. Internal solution in mM: CsF 135, NaCl 10,
HEPES 5 at pH 7.0. External solution in mM: NaCl 30, CsCl 5,
D-glucose 25, MgCl2 1, CaCl2 1.8, HEPES 5, tetraethylammonium
chloride 20, tetramethylammonium chloride 70 at pH 7.4. 200 nM
TTX was added to the external solution to separate TTX-R sodium
currents from TTX-S sodium currents.
Fig. 6. I^V relationships of Nav1.2/L1 and para/tipE at di¡erent
HNTX-I concentrations. The results of one oocyte are shown as an
example. No shift in the I^V curve was observed (I1/I1P= I2/I2P). I1,
I1P, I2 and I2P are indicated in the ¢gures. A: Nav1.2/L1. B: para/
tipE.
Table 1
Structural statistics for 20 structures of HNTX-I
Parameter Value
Experimental constraints
Intra-residue NOE (i^j=0) 155
Sequential NOE (Mi^jM=1) 99
Medium-range NOE (Mi^jM=5) 27
Long-range NOE (Mi^jM=5) 92
Dihedral angle (P) 10








r.m.s. deviation from experimental constraintsb
NOE distance (AS ) (392) 0.003U 0.001
Dihedral angle (‡) (10) 0.138U 0.127
r.m.s. deviations from idealized geometrya
Bonds (AS ) 0.003U 0.0001
Angles (‡) 0.536U 0.007
Impropers (‡) 0.336U 0.005
Average r.m.s. di¡erences versus mean structure (AS )
Backbone atoms (N, CK, C) 0.624U 0.073
Non-hydrogen heavy atoms 1.300U 0.130
Pairwise r.m.s. di¡erences of 20 structures (AS )
Backbone atoms (N, CK, C) 0.902U 0.139
Non-hydrogen heavy atoms 1.848U 0.204
aThe idealized geometry and energy values were de¢ned by the
CHARMM force ¢eld as implemented in the XPLOR program. All
statistical values of energies, r.m.s. deviations, and r.m.s. di¡erences
are given as the meanUS.D.
bThe statistics of experimental r.m.s. deviation of NOE and dihedral
angle constraints were from the calculation with force constants of
50 kcal/mol/AS 2 and 200 kcal/mol/rad2, respectively.
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and bond angles, respectively. Analysis of the structures in
PROCHECK shows that 83.3% of non-Pro, non-Gly residues
lie in the most favored regions of the Ramachandran plot.
16.7% are located in additionally allowed regions. A summary
of the structural statistics for HNTX-I is given in Table 1.
3.5. Description of structures
Fig. 7A shows a stereo pair representation of the best-¢t
superposition of the backbone atoms (N, CK, C) for the 20
converged structures of HNTX-I. Analysis of the 20 con-
verged structures indicates that the molecular structure of
HNTX-I contains a short triple-stranded anti-parallel L-sheet
formed by the strands Lys7^Cys9, Tyr20^Asn23 and Trp28^
Val31 respectively. The topology and constituting residues of
the L-sheet, determined by calculations, were found to be in
concordance with those determined by the analysis of second-
ary structures in our previous paper [28]. The turns in HNTX-
I were also identi¢ed using a standard de¢nition that states
that the distance between CK(i) and CK(i+3) should be less
than 7 AS and that the characteristic NOE connectivities of
backbone protons [26] for the corresponding turn segments
are present. These analyses led to the identi¢cation of four
L-turns, which were classi¢ed according to Richardson [29].
The four L-turns involve residues Gly4^Lys7 (type II), Val10^
Lys13 (type II), Cys17^Tyr20 (type II) and Ser24^Lys27
(type I).
The solution structure of HNTX-I shows a similar overall
molecular fold to that adopted by numerous toxic and inhib-
itory peptides, which is called the ICK motif. The cysteine
knot in HNTX-I is formed by three disul¢de bonds linked
as Cys2^Cys17, Cys9^Cys22 and Cys16^Cys29, in which the
Cys16^Cys29 disul¢de bond passes through a 14-residue ring
formed by the intervening polypeptide backbone and the
Cys2^Cys17 and Cys9^Cys22 disul¢de bonds.
4. Discussion
HNTX-I, isolated from the venom of O. hainana, is a novel
depressant spider toxin preferentially blocking insect VGSCs.
It neither slows channel inactivation nor shifts the reversal
potential, indicating that it does not a¡ect the ion selectivity
of both VGSCs which were tested (Nav1.2/L1 and para/tipE).
Compared with other depressant spider toxins such as
HWTX-IV and HNTX-III^V [9,10,30], HNTX-I has no e¡ect
on the VGSC subtypes in dorsal root ganglion neurons con-
taining rNav1.1, 1.6, 1.7, 1.8 and 1.9 (see Fig. 5C) nor on
rNav1.4 and 1.5 expressed on X. laevis oocytes (data not
shown), although none of them a¡ected the activation and
inactivation kinetics of sodium channels. HNTX-I can only
target other channel isoforms, namely rNav1.2 and para/tipE
channels, with IC50 values of 68U 6 WM and 4.3U 0.3 WM,
respectively. It seems that similar to TTX and ATXII,
HNTX-I is more potent on insect VGSCs than on their verte-
brate counterparts [7]. Spider toxins targeting insect sodium
channels emerge mainly in the excitatory toxins, such as
N-ACTXs and W-agatoxins [11^13]. However, clearly di¡erent
from these insect toxins, HNTX-I has no e¡ect on the inacti-
vation kinetics. The spider toxin HNTX-I reported here is the
¢rst to block insect sodium channels, and seems to be a site 1
toxin a¡ecting the sodium channel through a mechanism quite
Fig. 7. Solution structure characterization of HNTX-I. A: Stereo view of superimposition of backbone heavy atoms (N, CK, C) for 20 con-
verged structures of HNTX-I. The letters N and C refer to the amino- and carboxy-termini, respectively. B: Comparison of the surface pro¢le
of HNTX-I (PDB code 1NIX), HWTX-IV (PDB code 1MB6) and HWTX-I (PDB code 1QK6). Blue and red regions represent positively and
negatively charged residues, respectively. Green regions represent hydrophobic residues. C: Backbone superposition of HNTX-I (red), HWTX-I
(blue) and HWTX-IV (green). The ¢t was done using the common secondary structure elements. (For interpretation of the references to color
in this ¢gure legend, the reader is referred to the web version of this article.)
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similar to that of TTX. Thus, it de¢nes a new class of spider
toxins a¡ecting VGSCs, and could prove to be a novel useful
ligand to investigate the multiple molecular forms of VGSCs
in vertebrates as well as in insects.
4.1. Structure^function relationships of HNTX-I
Compared to other animal toxin groups, relatively little
structural information has been gathered on spider peptide
toxins a¡ecting VGSCs. Up to now, six NMR solution struc-
tures (including HNTX-I) and one model structure have been
deposited in the PDB (www.rcbs.org/pdb). Collectively, they
all adopt the ICK structural motif. However, these peptides
might possess a unique selectivity to mammals and/or insects
VGSCs, distinct potencies and diverse receptor binding spe-
ci¢cities. Of the structures deposited in the PDB, HNTX-I is
the only one reported so far as being an insect inhibitor.
Therefore, elucidation of the 3D structure of HNTX-I pro-
vides important clues on its toxin^receptor interaction.
In general, hydrophobic residue and polar residue hot spots
are important binding determinants in protein interactions
because of their conducting to energetically and structurally
favorable states [31]. Studies of site-directed mutagenesis in
VGSCs or their neurotoxins have also been carried out to
identify which residues are involved in the binding and block-
ing activity [8,32^36]. One important characteristic required
for blockage of sodium current is the presence of a positively
charged region on the toxin since two important amino acids
in the P loop form the negatively charged outer and inner
rings that served as a receptor site for pore blockers and the
selectively ¢lter. The resultant electrostatic forces conduce to
the attachment of the toxin to its binding site on the channel
[37]. Since HNTX-I inhibits VGSCs in both vertebrates and
insects, it should therefore present a similar type of interacting
surface. Such a basic pro¢le is also found in HNTX-I, in
which there is relative abundance of Arg and Lys residues
(Fig. 2), producing a net positive charge (theoretical
pI=8.65) on this molecule. The fact that the most solvent-
exposed Arg and Lys residues of loop IV are extremely well
conserved among the depressant spider toxins (Fig. 2) empha-
sizes the possibility that Arg25 and Lys27 in HNTX-I are the
most crucial residues for its blocking activity. Close to the two
residues are another basic residue Lys30, an acidic residue
Asp26, and a hydrophobic patch (Phe5, Tyr20, Trp28,
Val31, Leu32 and Leu33). Two other basic residues Lys3
and Lys7 are localized on the edge of the surface pro¢le
(Fig. 7B). The overall physicochemical characteristics of the
proposed functional surface formed by all of the above men-
tioned amino acids are therefore in accord with those of ion
channel inhibitors. From these data it is possible to conclude
that the basic nature of HNTX-I is a crucial factor for its
biological activity, and the surface of HNTX-I encompassing
the charged residues and a vicinal hydrophobic patch is re-
sponsible for binding to VGSCs in both vertebrates and in-
sects.
4.2. Structural comparisons of HNTX-I with HWTX-I and
HWTX-IV
HNTX-I is closely related in primary sequence to other
toxins from the venom of the Chinese bird spider Ornithocto-
nus (Fig. 2). Moreover, it shares a similar molecular folding to
that of HWTX-I, an N-type Ca2þ channel inhibitor [38,39],
and the mammal neuronal VGSC antagonist HWTX-IV [10]
(Fig. 6C). The sequence alignment and the structural compar-
ison of these toxins indicate that the hydrophobic residues and
most of the positively charged residues are fairly conserved.
However, the distributions of negatively charged residues are
obviously di¡erent (Fig. 7B). The residues corresponding to
Lys3 and Asp26 of HNTX-I are Glu4 and Arg26 of HWTX-
IV, respectively. The basic residue Lys7 in HNTX-I is
changed into the acidic residue Asp7 in HWTX-I. A detailed
analysis shows that Asp26 in HNTX-I and Asp24 in HWTX-I
exhibit a slightly di¡erent location and orientation. Such
subtle di¡erences of charged residues do not alter the overall
structure of the toxins but considerably a¡ect their electro-
static properties and result in additional pharmacological £ex-
ibility. Based on our results, we propose that the conserved
hydrophobic residue and positively charged residue hot spots
of these toxins act as an ion channel binding site anchor,
whereas the variable acidic residues and the local structure
di¡erences are considered to be responsible for their pharma-
cological speci¢city.
5. Conclusion
In summary, HNTX-I shows no e¡ect on the neuronal
TTX-S VGSCs in adult rat dorsal root ganglion neurons
nor does it target VGSCs in cardiac or skeletal muscles of
mammals. It selectively blocks rNav1.2/L1 and para/tipE chan-
nels expressed in X. laevis oocytes and displays a high potency
and e⁄cacy towards para/tipE. HNTX-I seems to act most
likely as a site 1 antagonist, a¡ecting the VGSCs through a
mechanism quite similar to that of TTX. Thus the character-
ization of HNTX-I and the investigation of its interaction
with VGSCs are very interesting. Given that HNTX-I targets
both insect and mammalian VGSCs, it possesses a consider-
able potential as a pharmacological tool for aiding in the
investigation of structural requirements for anti-insect versus
anti-mammal activity. In addition, the primary sequence and
structural details of the depressant toxin reported here provide
further information not only concerning structure^function
relationship but also regarding the design of genetic or syn-
thetic analogs for future functional studies.
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